Fast Five Quiz: HER2+ Breast Cancer

Pavani Chalasani, MD, MPH


August 23, 2022

Figure 1. Color-enhanced mammography showing breast cancer.

HER2+ breast cancer is characterized by early recurrence, rapid growth, and early metastasis, according to Markman and colleagues. It is more commonly diagnosed at an advanced stage than hormone receptor (HR)-positive, HER2-negative breast cancers.

Learn more about the characteristics of HER2+ breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.